OBJECTIVE: The study evaluated the DSM-IV definition of the atypical features specifier for a major depressive episode in major depressive disorder. METHOD: Nonpsychotic patients with major depressive disorder were assessed to determine if the DSM-IV model and decision rules for the atypical features specifier for a major depressive episode could be supported. RESULTS: The five clinical features of the DSM-IV atypical features specifier for a major depressive episode showed weak internal consistency, and the mandatory criterion A feature of mood reactivity did not show specificity in relation to any of the four criterion B accessory symptoms. The more severe the depression, the less likely the patient was to report criterion A and hence to meet criteria for the atypical features specifier. Remodeling the five features favored the personality style descriptor of interpersonal rejection sensitivity as an alternate primary feature. A reformulated model also suggested lifetime panic disorder and social phobia as higher-order determinants of atypical features in major depressive disorder. Additional analyses of criteria suggested that interpersonal rejection sensitivity and leaden paralysis had a phenomenological base in anxiety, that mood reactivity was linked with irritability, and that neither weight gain nor hypersomnia were clearly aligned with anxiety or depression, raising questions about their status as symptoms. CONCLUSIONS: The current definition and modeling of the DSM-IV atypical features specifier for a major depressive episode in major depressive disorder appears problematic. As suggested by earlier descriptions of atypical depression, certain expressions of anxiety may have primacy, and some clinical features associated with the DSM-IV model may be adaptive homeostatic responses rather than pathological symptoms.
OBJECTIVE: The study evaluated the DSM-IV definition of the atypical features specifier for a major depressive episode in major depressive disorder. METHOD:Nonpsychoticpatients with major depressive disorder were assessed to determine if the DSM-IV model and decision rules for the atypical features specifier for a major depressive episode could be supported. RESULTS: The five clinical features of the DSM-IV atypical features specifier for a major depressive episode showed weak internal consistency, and the mandatory criterion A feature of mood reactivity did not show specificity in relation to any of the four criterion B accessory symptoms. The more severe the depression, the less likely the patient was to report criterion A and hence to meet criteria for the atypical features specifier. Remodeling the five features favored the personality style descriptor of interpersonal rejection sensitivity as an alternate primary feature. A reformulated model also suggested lifetime panic disorder and social phobia as higher-order determinants of atypical features in major depressive disorder. Additional analyses of criteria suggested that interpersonal rejection sensitivity and leaden paralysis had a phenomenological base in anxiety, that mood reactivity was linked with irritability, and that neither weight gain nor hypersomnia were clearly aligned with anxiety or depression, raising questions about their status as symptoms. CONCLUSIONS: The current definition and modeling of the DSM-IV atypical features specifier for a major depressive episode in major depressive disorder appears problematic. As suggested by earlier descriptions of atypical depression, certain expressions of anxiety may have primacy, and some clinical features associated with the DSM-IV model may be adaptive homeostatic responses rather than pathological symptoms.
Authors: Carlos Blanco; Oriana Vesga-López; Jonathan W Stewart; Shang-Min Liu; Bridget F Grant; Deborah S Hasin Journal: J Clin Psychiatry Date: 2011-09-06 Impact factor: 4.384
Authors: Rebecca S Siegel; Bettina Hoeppner; Shirley Yen; Robert L Stout; Lauren M Weinstock; Heather M Hower; Boris Birmaher; Tina R Goldstein; Benjamin I Goldstein; Jeffrey I Hunt; Michael Strober; David A Axelson; Mary Kay Gill; Martin B Keller Journal: J Nerv Ment Dis Date: 2015-03 Impact factor: 2.254
Authors: Mary F Dallman; Norman Pecoraro; Susan F Akana; Susanne E La Fleur; Francisca Gomez; Hani Houshyar; M E Bell; Seema Bhatnagar; Kevin D Laugero; Sotara Manalo Journal: Proc Natl Acad Sci U S A Date: 2003-09-15 Impact factor: 11.205
Authors: Rebecca L Ross; Kim D Jones; Rachel L Ward; Lisa J Wood; Robert M Bennett Journal: BMC Musculoskelet Disord Date: 2010-06-14 Impact factor: 2.362
Authors: Mustafa M Husain; Shawn M McClintock; A John Rush; Rebecca G Knapp; Max Fink; Teresa A Rummans; Keith Rasmussen; Cynthia Claassen; Georgios Petrides; Melanie M Biggs; Martina Mueller; Shirlene Sampson; Samuel H Bailine; Sarah H Lisanby; Charles H Kellner Journal: J Clin Psychiatry Date: 2008-03 Impact factor: 4.384